Related Experiment Video
Updated: Oct 9, 2025

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder
Zanda Daneberga1,2, Miki Nakazawa-Miklasevica1, Egija Berga-Svitina1
1Institute of Oncology, Riga Stradins University, Riga, Latvia.
Insights
Urinary organic acids may indicate gut microbiota changes in autistic children, but require caution. P-cresol and HPHPA levels showed variations, suggesting potential links to specific bacteria like Firmicutes.
Area of Science:
- Microbiology
- Neuroscience
- Biochemistry
Background:
- Gut microbiota alterations are linked to neurodevelopmental disorders like autistic spectrum disorder (ASD).
- Children with ASD often exhibit changes in urinary organic acid profiles, suggesting potential biomarkers for gastrointestinal dysbiosis.
Purpose of the Study:
- To identify urinary metabolites indicative of specific gut microbiota changes in children with ASD.
- To evaluate the utility of these metabolites as potential biomarkers for gut dysbiosis.
Main Methods:
- Analysis of urinary organic acid spectra in 44 children with ASD.
- Assessment of gut microbiota composition in the same study group.
Main Results:
- No significant deviations in overall quantified urinary metabolites were confirmed compared to reference values.
- Elevated p-cresol and 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA) concentrations were noted.
- Higher relative abundance of the Firmicutes phylum correlated with increased p-cresol.
- A decreased Bacteroidetes/Firmicutes ratio was observed in children with HPHPA present in urine.
Conclusions:
- Urinary metabolites can serve as biomarkers for gut microbiota alterations in ASD, but require cautious interpretation.
- Treatment decisions should be guided by comprehensive gut microbiota analysis, potentially combined with urinary organic acid data, not solely by organic acid biomarkers.
Abstract:
Introduction: Alteration of human gut microbiota is described in a number of neuro-developmental and cognitive disorders including autistic spectrum disorder (ASD). Along with the changes in the gut microbiota, children with ASD are also reported to have changes in urinary organic acid spectra implying these metabolites as potential biomarkers for gastrointestinal dysbiosis.Aim: Identify urinary metabolites that would indicate specific changes in the gut microbiota and could be useful as biomarkers.Methods: The study group consisted of 44 children with ASD. Urinary organic acids spectra and composition of gut microbiota were analysed.Results: Any significant deviation in quantified metabolites compared to the reference values were not confirmed. The main variations were detected in concentration of p-cresol and 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), but we cannot confirm the presence of HPHPA in urine as a biomarker for Clostridium sp. overgrowth in the gut. The acquired results indicate higher relative abundance of Firmicutes phylum alone may be attributed to increased concentration of p-cresol in urine. Decreased Bacteroidetes/Firmicutes ratio was found in the group with the presence of HPHPA in urine.Conclusions: Metabolites of human urine can be used as biomarkers for alterations of gut microbiota with caution, guided treatment should be administrated only based on gut microbiota analysis results or in combination with urinary organic acid results, but not solely based on organic acid biomarkers.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Urine Studies I: Urinalysis
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

